Daniel Weisel, MD
Family Practice · O Fallon
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 9 years
- Washington University School of Medicine, 2017
Offices
2 locations · Physician Groups Lc · Aging Well Health Care, LLC
Looking this up.
Hospitals listed: Barnes Jewish Hospital · Barnes-Jewish St Peters Hospital · Barnes-Jewish West County Hospital · Missouri Baptist Medical Center · Progress West Hospital · SSM Health Rehabilitation Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Weisel’s office at (636) 344-2400 to ask if they take your plan before you enroll.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Barnes Jewish HospitalSaint Louis, MOAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of BJC Healthcare, which runs 16 hospitals in 2 statesHome of Alvin J. Siteman Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.6 (11.1 to 14.2) · 1,529 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.552, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.648, Oct 2024 – Sep 2025
- Barnes-Jewish St Peters HospitalSaint Peters, MOAcute Care Hospital · Voluntary non-profit - Other · Has an emergency departmentPart of BJC Healthcare, which runs 16 hospitals in 2 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Barnes-Jewish West County HospitalCreve Coeur, MOAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of BJC Healthcare, which runs 16 hospitals in 2 statesPatients rate it 4 of 5 · 88% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — SSI - Colon Surgery: 0.174, Oct 2024 – Sep 2025
- Missouri Baptist Medical CenterSaint Louis, MOAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of BJC Healthcare, which runs 16 hospitals in 2 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14 (11.3 to 17.5) · 306 cases, Jan 2024 – Dec 2024Better than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.71 (0.48 to 0.94), Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.336, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.585, Oct 2024 – Sep 2025
- Progress West HospitalOfallon, MOAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of BJC Healthcare, which runs 16 hospitals in 2 statesPatients rate it 4 of 5 · 82% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Barnes Jewish Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (11.1 to 14.2) · 1,529 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.552 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.648 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.81 (0.22 to 1.39) · 5,827 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.82 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 157.2 (133.44 to 180.96) · 676 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.5 · 162 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 127 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.8 · 127 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 536 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 360 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 630 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 7,682 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.08 to 0.39) · 19,562 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.04 to 0.34) · 21,285 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.68 (1.62 to 3.75) · 7,936 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.02 (1.22 to 2.81) · 4,451 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (1.29 to 2.93) · 6,874 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (7.29 to 11.79) · 4,092 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.26 (3.72 to 6.8) · 4,418 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.44 (0.35 to 2.54) · 2,300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.32 to 0.91) · 18,767 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 77 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.788 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.726 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.36 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.252 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 374 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.9 · 1,156 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 227 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 34.9 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -10 · 379 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.9 to 6) · 1,529 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 314 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.8 to 16.1) · 1,580 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,767 cases | No different | Jan 2024 – Dec 2024 |
What patients said (7,124 patients answered, 35% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Barnes-Jewish St Peters Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.91 (0 to 1.92) · 597 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.61 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 173.19 (117.39 to 228.99) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 263 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 333 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14 · 346 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,430 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,548 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.52) · 3,589 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.07 (0.76 to 5.38) · 655 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.29) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.43 to 3.69) · 605 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.28 (4.55 to 22.02) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.33 (2.23 to 10.42) · 229 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 166 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.04) · 2,997 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 114 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.79 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.036 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.75 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.73 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.842 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 133 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.7 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 4.8 · 69 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7 · 286 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.2 · 342 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.1 to 8.2) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.5 to 15.2) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 121 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.4 to 18.1) · 763 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 477 cases | No different | Jan 2024 – Dec 2024 |
What patients said (867 patients answered, 33% of those asked)
| Cleanliness | 1 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 52% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Barnes-Jewish West County Hospital
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 6 the same, 0 worse of 6 measures. Readmissions: 1 better, 4 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 0.174 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.82 (0 to 1.78) · 600 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.77 (0.36 to 1.19) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 62 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11 · 68 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 957 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,944 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,939 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.6 (0.32 to 4.88) · 690 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.51 (0 to 3.16) · 513 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.98 to 4.21) · 677 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.99 (0 to 14.68) · 529 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.3 (0.68 to 7.92) · 477 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 1.44) · 1,298 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 70 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.016 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.786 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.267 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.7 · 107 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 32.1 · 63 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -46.5 · 74 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 109 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 30 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.1 (11.2 to 17.7) · 2,223 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.2) · 1,244 cases | No different | Jan 2024 – Dec 2024 |
What patients said (522 patients answered, 36% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 83% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 80% |
| "YES", patients would definitely recommend the hospital | 88% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Missouri Baptist Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 2 better, 8 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14 (11.3 to 17.5) · 306 cases | Worse | Jan 2024 – Dec 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.71 (0.48 to 0.94) | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.336 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.585 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.74 (0 to 1.55) · 2,733 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 152.17 (108.13 to 196.21) · 134 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.6 · 246 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.8 · 913 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 703 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 6,256 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,072 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.12 to 0.48) · 11,554 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.26 (0.58 to 3.95) · 3,010 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.78 (0.57 to 3) · 1,434 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.65 (0.36 to 2.93) · 2,505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.8 (1.76 to 9.83) · 1,431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.92 (2.14 to 7.71) · 1,386 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 728 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.71) · 9,346 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 155 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.617 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.553 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.327 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 397 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,495 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 2 · 275 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12.6 · 1,034 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 9.7 · 735 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 968 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.7 to 7.2) · 306 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.4 · 155 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.1 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.8 · 218 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (10.3 to 16.8) · 1,716 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,088 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,956 patients answered, 35% of those asked)
| Cleanliness | 2 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Progress West Hospital
Behind the star rating — Deaths: 1 better, 5 the same, 0 worse of 6 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 6 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.08) · 275 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.58 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 57 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 125 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.3 · 191 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,298 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,790 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,766 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.56 (1.07 to 6.05) · 296 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 88 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.23 (0.53 to 3.92) · 274 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.63 (0 to 18.39) · 91 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.14 (0.84 to 9.44) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 64 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.83 (0 to 1.87) · 1,467 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 89 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.313 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 73 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 264 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -4.8 · 140 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -15.8 · 195 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 324 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 79 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.8 to 17.2) · 780 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 253 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 34% of those asked)
| Cleanliness | 3 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 80% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 64% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$66,169
Medicare paid this office $66,169 for 247 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 149 | $18,441 | $82 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 118 | $14,683 | $124 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $4,062 | $290 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $3,792 | $60 |
| Transitional care management services for problem of at least moderate complexity | 17 | $3,149 | $157 |
See all 17 services
| Return visit (30+ min) | 149 | $18,441 | $82 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 118 | $14,683 | $124 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $4,062 | $290 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $3,792 | $60 |
| Transitional care management services for problem of at least moderate complexity | 17 | $3,149 | $157 |
| Influenza vaccine split virus, preservative free | 36 | $3,008 | $81 |
| Sarscv2 vac 30mcg trs-suc im | 22 | $2,867 | $130 |
| Short return visit (20+ min) | 42 | $2,866 | $58 |
| New patient visit (45+ min) | 20 | $1,482 | $74 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,456 | $121 |
| Insertion of needle into vein for collection of blood sample | 123 | $1,453 | $9 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,307 | $87 |
| Administration of influenza virus vaccine | 39 | $1,248 | $31 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,097 | $100 |
| Admn sarscov2 vacc 1 dose | 22 | $862 | $39 |
| Administration of pneumococcal vaccine | 14 | $437 | $31 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 18 | $227 | $11 |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
247 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 12% · Women 41% · Also on Medicaid 5% · Health risk score 1.21. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 32% · Chronic kidney disease 28% · Coronary heart disease 27% · Atrial fibrillation 21% · Depression 21% · Cancer 17% · COPD 17% · Heart failure 16% · Stroke 10% · Dementia 7%.
The office billed $151,235, Medicare allowed $82,405 and paid $66,169; for 979 services of 48 kinds; $10,573 of it was for drugs given in the office and $55,596 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 247 | 979 | 74 | 1.21 | $151,235 | $66,169 |
| 2023 | 223 | 827 | 74 | 1.19 | $136,562 | $60,233 |
| 2022 | 183 | 756 | 73 | 1.16 | $121,667 | $53,005 |
| 2021 | 119 | 437 | 72 | 1.37 | $67,337 | $29,508 |
| 2020 | 16 | 49 | 74 | 2.27 | $8,160 | $3,817 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Return visit (30+ min) | 135 | $17,659 | $87 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 103 | $12,889 | $125 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 30 | $8,467 | $282 |
| New patient visit (45+ min) | 44 | $3,696 | $84 |
| Short return visit (20+ min) | 37 | $2,340 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,330 | $58 |
| Transitional care management services for problem of at least moderate complexity | 14 | $2,209 | $158 |
| Influenza vaccine split virus, preservative free | 23 | $1,651 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,615 | $115 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,420 | $89 |
| Insertion of needle into vein for collection of blood sample | 119 | $1,319 | $8 |
| Administration of pneumococcal vaccine | 30 | $898 | $30 |
| Administration of influenza virus vaccine | 25 | $749 | $30 |
2022: 16 services
| Return visit (30+ min) | 89 | $13,708 | $85 |
| New patient visit (45+ min) | 51 | $5,704 | $112 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | $5,144 | $129 |
| Short return visit (20+ min) | 52 | $4,178 | $61 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 11 | $3,059 | $278 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,619 | $56 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $1,814 | $165 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,719 | $101 |
| Transitional care management services for problem of at least moderate complexity | 11 | $1,639 | $149 |
| Pneumococcal vaccine, 23-valent | 12 | $1,591 | $133 |
| Influenza vaccine split virus, preservative free | 23 | $1,573 | $68 |
| Hospital discharge day management, more than 30 minutes | 11 | $985 | $82 |
| Administration of pneumococcal vaccine | 26 | $760 | $29 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $752 | $30 |
| Administration of influenza virus vaccine | 25 | $725 | $29 |
| Insertion of needle into vein for collection of blood sample | 93 | $296 | $3 |
2021: 10 services
| Return visit (30+ min) | 56 | $8,494 | $93 |
| New patient visit (45+ min) | 37 | $3,670 | $99 |
| Short return visit (20+ min) | 38 | $3,456 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,932 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,711 | $132 |
| Influenza vaccine split virus, preservative free | 13 | $848 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $395 | $30 |
| Administration of influenza virus vaccine | 15 | $252 | $17 |
| Administration of pneumococcal vaccine | 12 | $201 | $17 |
| Insertion of needle into vein for collection of blood sample | 52 | $159 | $3 |
Medicaid work
$6,650 in 2024
Medicaid paid $6,650 for 63 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 63 | $6,650 |
| 2024 | 63 | 1 | 18 | $6,650 |
| 2023 | 123 | 1 | 17 | $13,902 |
| 2022 | 35 | 1 | 17 | $2,305 |
| 2021 | 28 | 1 | 14 | $1,573 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 123 | $13,902 |
2022
| Return visit (30+ min) | 35 | $2,305 |
2021
| Return visit (30+ min) | 28 | $1,573 |
Drugs they prescribed that Part D paid
$594,385
Pharmacies billed $594,385 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (153 of 7,899) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
7,086 generic and 783 brand-name prescriptions · $594,385 in drug cost · 141 antibiotic prescriptions to 100 people · 25 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 99 | $107,754 | $1,088 |
| Trulicity | 41 | $62,446 | $1,523 |
| Jardiance | 40 | $52,208 | $1,305 |
| Mounjaro | 30 | $33,397 | $1,113 |
| Januvia | 19 | $18,904 | $995 |
See all 126 drugs
| Eliquis | 99 | $107,754 | $1,088 |
| Trulicity | 41 | $62,446 | $1,523 |
| Jardiance | 40 | $52,208 | $1,305 |
| Mounjaro | 30 | $33,397 | $1,113 |
| Januvia | 19 | $18,904 | $995 |
| Ozempic | 14 | $18,722 | $1,337 |
| Anoro Ellipta | 31 | $17,638 | $569 |
| Arexvy | 46 | $12,186 | $265 |
| Breo Ellipta | 25 | $11,735 | $469 |
| Linzess | 13 | $9,275 | $713 |
| Atorvastatin | 573 | $4,428 | $8 |
| Gabapentin | 190 | $4,386 | $23 |
| Lantus Solostar | 31 | $4,237 | $137 |
| Pantoprazole | 182 | $2,889 | $16 |
| Metoprolol | 209 | $2,431 | $12 |
| Levothyroxine | 255 | $2,163 | $8 |
| Omeprazole | 186 | $1,941 | $10 |
| Tamsulosin | 132 | $1,920 | $15 |
| Amlodipine Besylate | 340 | $1,870 | $5 |
| Rosuvastatin | 189 | $1,859 | $10 |
| Synthroid | 22 | $1,814 | $82 |
| Albuterol Sulfate Hfa | 67 | $1,671 | $25 |
| Lisinopril | 343 | $1,646 | $5 |
| Irbesartan | 49 | $1,458 | $30 |
| Escitalopram | 102 | $1,405 | $14 |
| Losartan | 217 | $1,322 | $6 |
| Midodrine | 14 | $1,128 | $81 |
| Pregabalin | 24 | $1,102 | $46 |
| Celecoxib | 47 | $1,060 | $23 |
| Duloxetine | 51 | $1,040 | $20 |
| Diclofenac | 26 | $968 | $37 |
| Montelukast | 99 | $931 | $9 |
| Pravastatin | 87 | $813 | $9 |
| Nebivolol | 11 | $804 | $73 |
| Bupropion Xl | 28 | $780 | $28 |
| Metformin Hcl Er | 112 | $756 | $7 |
| Baclofen | 34 | $754 | $22 |
| Ezetimibe | 43 | $748 | $17 |
| Cyclobenzaprine | 59 | $734 | $12 |
| Trazodone | 105 | $685 | $7 |
| Clopidogrel | 61 | $668 | $11 |
| Venlafaxine Hcl Er | 27 | $652 | $24 |
| Hydrocodone-Acetaminophen | 68 | $650 | $10 |
| Fluoxetine | 49 | $636 | $13 |
| Metformin | 115 | $616 | $5 |
| Metoprolol | 104 | $614 | $6 |
| Mirtazapine | 18 | $611 | $34 |
| Simvastatin | 117 | $596 | $5 |
| Hydrochlorothiazide | 144 | $582 | $4 |
| Diltiazem 24hr Er (Xr) | 11 | $579 | $53 |
| Finasteride | 50 | $576 | $12 |
| Valacyclovir | 22 | $571 | $26 |
| Olmesartan Medoxomil | 55 | $569 | $10 |
| Sertraline | 46 | $565 | $12 |
| Glipizide | 63 | $556 | $9 |
| Temazepam | 14 | $555 | $40 |
| Lidocaine | 20 | $536 | $27 |
| Quetiapine | 28 | $524 | $19 |
| Famotidine | 53 | $523 | $10 |
| Fluticasone Propionate | 49 | $502 | $10 |
| Allopurinol | 66 | $442 | $7 |
| Furosemide | 81 | $436 | $5 |
| Valsartan-Hydrochlorothiazide | 11 | $435 | $40 |
| Oxycodone-Acetaminophen | 25 | $435 | $17 |
| Buspirone | 27 | $421 | $16 |
| Losartan-Hydrochlorothiazide | 59 | $413 | $7 |
| Pramipexole Dihydrochloride | 18 | $403 | $22 |
| Telmisartan | 13 | $398 | $31 |
| Glimepiride | 53 | $397 | $7 |
| Nitrofurantoin Mono-Macro | 23 | $376 | $16 |
| Carvedilol | 48 | $368 | $8 |
| Alendronate | 49 | $365 | $7 |
| Memantine | 21 | $364 | $17 |
| Paroxetine | 20 | $350 | $18 |
| Nitroglycerin | 18 | $345 | $19 |
| Ondansetron Odt | 40 | $340 | $9 |
| Spironolactone | 47 | $335 | $7 |
| Oxybutynin Chloride | 13 | $333 | $26 |
| Potassium Chloride | 28 | $321 | $11 |
| Zolpidem | 43 | $320 | $7 |
| Lisinopril-Hydrochlorothiazide | 49 | $314 | $6 |
| Hydroxyzine | 21 | $309 | $15 |
| Esomeprazole Magnesium | 11 | $296 | $27 |
| Glipizide Er | 20 | $296 | $15 |
| Dextroamphetamine-Amphetamine | 15 | $294 | $20 |
| Isosorbide Mononitrate Er | 16 | $281 | $18 |
| Chlorthalidone | 12 | $280 | $23 |
| Verapamil Er | 12 | $270 | $22 |
| Meloxicam | 69 | $268 | $4 |
| Lovastatin | 21 | $248 | $12 |
| Bupropion Hcl Sr | 13 | $245 | $19 |
| Naproxen | 29 | $236 | $8 |
| Vitamin D2 | 18 | $235 | $13 |
| Ketoconazole | 24 | $234 | $10 |
| Fenofibrate | 12 | $231 | $19 |
| Tramadol | 41 | $225 | $5 |
| Sumatriptan | 13 | $217 | $17 |
| Tizanidine | 20 | $216 | $11 |
| Citalopram Hbr | 54 | $214 | $4 |
| Olmesartan-Hydrochlorothiazide | 12 | $201 | $17 |
| Amlodipine Besylate-Benazepril | 15 | $198 | $13 |
| Lorazepam | 45 | $188 | $4 |
| Methocarbamol | 11 | $188 | $17 |
| Prednisone | 53 | $182 | $3 |
| Alprazolam | 78 | $181 | $2 |
| Nabumetone | 14 | $175 | $13 |
| Oxycodone | 18 | $173 | $10 |
| Meclizine | 31 | $166 | $5 |
| Sulfamethoxazole-Trimethoprim | 20 | $163 | $8 |
| Oxybutynin Chloride Er | 11 | $155 | $14 |
| Methylprednisolone | 18 | $145 | $8 |
| Amitriptyline | 14 | $140 | $10 |
| Pioglitazone | 20 | $132 | $7 |
| Levofloxacin | 11 | $128 | $12 |
| Warfarin | 22 | $121 | $6 |
| Hydralazine | 20 | $118 | $6 |
| Clonidine | 28 | $109 | $4 |
| Ondansetron | 20 | $105 | $5 |
| Amoxicillin-Clavulanate Potass | 13 | $97 | $7 |
| Atenolol | 18 | $88 | $5 |
| Azithromycin | 22 | $84 | $4 |
| Hydrocortisone | 19 | $84 | $4 |
| Topiramate | 12 | $59 | $5 |
| Cephalexin | 13 | $51 | $4 |
| Triamterene-Hydrochlorothiazid | 11 | $48 | $4 |
| Clonazepam | 18 | $34 | $2 |
Year by year
| 2024 | 7,899 | 913 | 2% (153) | 10% | $594,385 |
| 2023 | 5,646 | 524 | 2% (98) | 10% | $431,689 |
| 2022 | 3,399 | 349 | 2% (62) | 10% | $309,799 |
| 2021 | 1,308 | 221 | 2% (27) | 15% | $134,761 |
| 2020 | 544 | 84 | None | None | $29,573 |
| 2019 | 489 | 75 | None | None | $72,161 |
| 2018 | 75 | 20 | None | 17% | $3,171 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 109 drugs
| Eliquis | 65 | $63,609 | $979 |
| Trulicity | 18 | $33,588 | $1,866 |
| Humalog Kwikpen U-100 | 12 | $28,347 | $2,362 |
| Jardiance | 22 | $27,568 | $1,253 |
| Ozempic | 19 | $22,003 | $1,158 |
| Arexvy | 68 | $21,722 | $319 |
| Lantus Solostar | 26 | $18,368 | $706 |
| Myrbetriq | 19 | $17,514 | $922 |
| Januvia | 16 | $13,119 | $820 |
| Anoro Ellipta | 12 | $5,912 | $493 |
| Novolog Flexpen | 12 | $5,813 | $484 |
| Levemir Flexpen | 12 | $5,402 | $450 |
| Breo Ellipta | 11 | $4,744 | $431 |
| Atorvastatin | 396 | $4,417 | $11 |
| Gabapentin | 168 | $3,972 | $24 |
| Fluticasone-Salmeterol | 16 | $3,755 | $235 |
| Levothyroxine | 180 | $3,039 | $17 |
| Tamsulosin | 120 | $2,923 | $24 |
| Rosuvastatin | 104 | $2,850 | $27 |
| Metoprolol | 119 | $2,481 | $21 |
| Celecoxib | 42 | $2,472 | $59 |
| Pantoprazole | 108 | $2,104 | $19 |
| Albuterol Sulfate Hfa | 78 | $1,916 | $25 |
| Duloxetine | 61 | $1,726 | $28 |
| Omeprazole | 118 | $1,721 | $15 |
| Lisinopril | 231 | $1,685 | $7 |
| Amlodipine Besylate | 195 | $1,534 | $8 |
| Pravastatin | 71 | $1,451 | $20 |
| Losartan | 127 | $1,413 | $11 |
| Midodrine | 16 | $1,343 | $84 |
| Irbesartan | 35 | $1,341 | $38 |
| Escitalopram | 94 | $1,325 | $14 |
| Finasteride | 47 | $1,218 | $26 |
| Bumetanide | 14 | $1,076 | $77 |
| Diclofenac | 20 | $1,057 | $53 |
| Metformin | 105 | $1,052 | $10 |
| Diltiazem 24hr Er (Xr) | 15 | $1,016 | $68 |
| Ezetimibe | 39 | $954 | $24 |
| Clopidogrel | 59 | $945 | $16 |
| Valsartan-Hydrochlorothiazide | 14 | $936 | $67 |
| Baclofen | 20 | $929 | $46 |
| Potassium Chloride | 26 | $797 | $31 |
| Metformin Hcl Er | 68 | $746 | $11 |
| Olmesartan Medoxomil | 38 | $738 | $19 |
| Venlafaxine Hcl Er | 28 | $730 | $26 |
| Allopurinol | 43 | $718 | $17 |
| Carvedilol | 49 | $704 | $14 |
| Furosemide | 80 | $704 | $9 |
| Glipizide | 35 | $687 | $20 |
| Montelukast | 56 | $668 | $12 |
| Fluoxetine | 32 | $652 | $20 |
| Famotidine | 41 | $629 | $15 |
| Hydrocodone-Acetaminophen | 48 | $610 | $13 |
| Simvastatin | 68 | $605 | $9 |
| Losartan-Hydrochlorothiazide | 25 | $589 | $24 |
| Hydrochlorothiazide | 96 | $583 | $6 |
| Sertraline | 50 | $580 | $12 |
| Fluticasone Propionate | 40 | $551 | $14 |
| Metoprolol | 69 | $542 | $8 |
| Trazodone | 56 | $444 | $8 |
| Glimepiride | 25 | $441 | $18 |
| Dicyclomine | 20 | $421 | $21 |
| Buspirone | 46 | $420 | $9 |
| Spironolactone | 37 | $410 | $11 |
| Pramipexole Dihydrochloride | 16 | $407 | $25 |
| Naproxen | 33 | $406 | $12 |
| Oxycodone-Acetaminophen | 20 | $371 | $19 |
| Bupropion Xl | 12 | $359 | $30 |
| Lisinopril-Hydrochlorothiazide | 33 | $347 | $11 |
| Lovastatin | 31 | $329 | $11 |
| Oxybutynin Chloride | 21 | $326 | $16 |
| Nabumetone | 29 | $308 | $11 |
| Citalopram Hbr | 30 | $303 | $10 |
| Isosorbide Mononitrate Er | 16 | $302 | $19 |
| Ondansetron Odt | 24 | $295 | $12 |
| Pregabalin | 12 | $282 | $24 |
| Meloxicam | 48 | $280 | $6 |
| Nitrofurantoin Mono-Macro | 17 | $270 | $16 |
| Chlorthalidone | 11 | $268 | $24 |
| Quetiapine | 18 | $262 | $15 |
| Fenofibrate | 13 | $252 | $19 |
| Nitroglycerin | 20 | $244 | $12 |
| Alendronate | 30 | $239 | $8 |
| Ondansetron | 14 | $235 | $17 |
| Valacyclovir | 11 | $224 | $20 |
| Paroxetine | 13 | $217 | $17 |
| Paxlovid (Eua) | 20 | $212 | $11 |
| Amlodipine Besylate-Benazepril | 17 | $201 | $12 |
| Hydroxyzine | 21 | $201 | $10 |
| Prednisone | 44 | $179 | $4 |
| Atenolol | 23 | $166 | $7 |
| Torsemide | 12 | $159 | $13 |
| Lorazepam | 31 | $158 | $5 |
| Meclizine | 16 | $156 | $10 |
| Tizanidine | 18 | $148 | $8 |
| Cyclobenzaprine | 29 | $141 | $5 |
| Methylprednisolone | 16 | $141 | $9 |
| Azithromycin | 39 | $140 | $4 |
| Vitamin D2 | 18 | $127 | $7 |
| Clonidine | 16 | $122 | $8 |
| Zolpidem | 16 | $112 | $7 |
| Amoxicillin-Clavulanate Potass | 13 | $105 | $8 |
| Triamcinolone Acetonide | 14 | $103 | $7 |
| Oxycodone | 11 | $86 | $8 |
| Alprazolam | 39 | $75 | $2 |
| Levofloxacin | 15 | $74 | $5 |
| Clonazepam | 19 | $45 | $2 |
| Sulfamethoxazole-Trimethoprim | 12 | $42 | $4 |
| Tramadol | 18 | $21 | $1 |
2022: 75 drugs
| Humalog Kwikpen U-100 | 21 | $38,047 | $1,812 |
| Eliquis | 32 | $33,503 | $1,047 |
| Trulicity | 14 | $20,888 | $1,492 |
| Jardiance | 19 | $16,983 | $894 |
| Lantus Solostar | 27 | $12,208 | $452 |
| Xarelto | 11 | $6,246 | $568 |
| Gabapentin | 145 | $3,212 | $22 |
| Atorvastatin | 205 | $2,097 | $10 |
| Levothyroxine | 98 | $1,825 | $19 |
| Albuterol Sulfate Hfa | 43 | $1,709 | $40 |
| Tamsulosin | 79 | $1,647 | $21 |
| Rosuvastatin | 76 | $1,586 | $21 |
| Diclofenac | 29 | $1,476 | $51 |
| Celecoxib | 16 | $1,312 | $82 |
| Nano 2nd Gen Pen Needle | 11 | $1,238 | $113 |
| Omeprazole | 55 | $1,070 | $19 |
| Duloxetine | 32 | $1,065 | $33 |
| Escitalopram | 72 | $1,057 | $15 |
| Metoprolol | 45 | $991 | $22 |
| Losartan | 72 | $876 | $12 |
| Ezetimibe | 18 | $829 | $46 |
| Allopurinol | 35 | $828 | $24 |
| Irbesartan | 18 | $784 | $44 |
| Amlodipine Besylate | 101 | $747 | $7 |
| Venlafaxine Hcl Er | 26 | $712 | $27 |
| Loperamide | 19 | $707 | $37 |
| Lisinopril | 126 | $676 | $5 |
| Montelukast | 34 | $649 | $19 |
| Pravastatin | 38 | $626 | $16 |
| Metformin | 83 | $621 | $7 |
| Fluticasone Propionate | 30 | $614 | $20 |
| Furosemide | 65 | $593 | $9 |
| Metoprolol | 43 | $559 | $13 |
| Finasteride | 27 | $518 | $19 |
| Midodrine | 11 | $505 | $46 |
| Olmesartan Medoxomil | 32 | $465 | $15 |
| Naproxen | 36 | $448 | $12 |
| Citalopram Hbr | 41 | $438 | $11 |
| Pantoprazole | 33 | $430 | $13 |
| Hydrocodone-Acetaminophen | 36 | $408 | $11 |
| Buspirone | 22 | $399 | $18 |
| Potassium Chloride | 12 | $368 | $31 |
| Isosorbide Mononitrate Er | 16 | $368 | $23 |
| Losartan-Hydrochlorothiazide | 11 | $363 | $33 |
| Famotidine | 31 | $363 | $12 |
| Ondansetron Odt | 15 | $357 | $24 |
| Sertraline | 27 | $341 | $13 |
| Bupropion | 12 | $340 | $28 |
| Clopidogrel | 23 | $339 | $15 |
| Oxycodone-Acetaminophen | 17 | $309 | $18 |
| Metformin Hcl Er | 33 | $305 | $9 |
| Cyclobenzaprine | 19 | $282 | $15 |
| Oxybutynin Chloride | 17 | $276 | $16 |
| Lovastatin | 27 | $274 | $10 |
| Zolpidem | 29 | $265 | $9 |
| Glimepiride | 15 | $258 | $17 |
| Trazodone | 29 | $233 | $8 |
| Lisinopril-Hydrochlorothiazide | 20 | $231 | $12 |
| Meloxicam | 31 | $228 | $7 |
| Hydrochlorothiazide | 57 | $226 | $4 |
| Methocarbamol | 14 | $205 | $15 |
| Carvedilol | 21 | $204 | $10 |
| Simvastatin | 27 | $186 | $7 |
| Meclizine | 25 | $173 | $7 |
| Lorazepam | 31 | $169 | $5 |
| Glipizide | 26 | $163 | $6 |
| Tizanidine | 16 | $147 | $9 |
| Prednisone | 32 | $143 | $4 |
| Levofloxacin | 15 | $133 | $9 |
| Amoxicillin-Clavulanate Potass | 11 | $110 | $10 |
| Azithromycin | 14 | $109 | $8 |
| Buprenorphine-Naloxone | 11 | $100 | $9 |
| Atenolol | 11 | $85 | $8 |
| Donepezil | 11 | $82 | $7 |
| Alprazolam | 15 | $68 | $5 |
2021: 28 drugs
| Eliquis | 24 | $16,512 | $688 |
| Lantus Solostar | 18 | $6,339 | $352 |
| Gabapentin | 62 | $1,149 | $19 |
| Nano 2nd Gen Pen Needle | 16 | $882 | $55 |
| Diclofenac | 19 | $660 | $35 |
| Atorvastatin | 75 | $629 | $8 |
| Levothyroxine | 35 | $594 | $17 |
| Rosuvastatin | 26 | $564 | $22 |
| Amlodipine Besylate | 65 | $560 | $9 |
| Losartan | 44 | $422 | $10 |
| Escitalopram | 21 | $360 | $17 |
| Omeprazole | 12 | $340 | $28 |
| Metoprolol | 25 | $291 | $12 |
| Allopurinol | 13 | $269 | $21 |
| Lisinopril | 47 | $247 | $5 |
| Metformin | 30 | $230 | $8 |
| Hydrocodone-Acetaminophen | 19 | $200 | $11 |
| Lorazepam | 14 | $194 | $14 |
| Furosemide | 31 | $194 | $6 |
| Naproxen | 23 | $193 | $8 |
| Tamsulosin | 11 | $151 | $14 |
| Metoprolol | 25 | $151 | $6 |
| Ondansetron | 16 | $133 | $8 |
| Citalopram Hbr | 17 | $127 | $7 |
| Prednisone | 26 | $115 | $4 |
| Trazodone | 15 | $102 | $7 |
| Hydrochlorothiazide | 26 | $79 | $3 |
| Folic Acid | 14 | $53 | $4 |
2020: 14 drugs
| Flovent Hfa | 12 | $5,381 | $448 |
| Gabapentin | 21 | $468 | $22 |
| Atorvastatin | 41 | $365 | $9 |
| Levothyroxine | 16 | $346 | $22 |
| Tamsulosin | 16 | $246 | $15 |
| Pravastatin | 11 | $184 | $17 |
| Losartan | 20 | $179 | $9 |
| Venlafaxine | 11 | $139 | $13 |
| Fluticasone Propionate | 13 | $135 | $10 |
| Metformin | 24 | $133 | $6 |
| Metoprolol | 26 | $126 | $5 |
| Amlodipine Besylate | 22 | $106 | $5 |
| Hydrochlorothiazide | 22 | $89 | $4 |
| Lisinopril | 20 | $64 | $3 |
2019: 12 drugs
| Flovent Hfa | 12 | $5,518 | $460 |
| Gabapentin | 11 | $692 | $63 |
| Atorvastatin | 43 | $393 | $9 |
| Tamsulosin | 16 | $281 | $18 |
| Levothyroxine | 15 | $251 | $17 |
| Risperidone | 11 | $171 | $16 |
| Fluticasone Propionate | 11 | $163 | $15 |
| Hydrochlorothiazide | 29 | $148 | $5 |
| Metoprolol | 26 | $145 | $6 |
| Lisinopril | 22 | $128 | $6 |
| Losartan | 11 | $115 | $10 |
| Sertraline | 14 | $112 | $8 |
Money from drug and device companies
$108 in 2024
| 2024 | 5 | 6 | None | $108 |
| 2023 | 4 | 10 | None | $158 |
| 2022 | 2 | 4 | None | $55 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Otezla | $35 | 2 payments
|
| Abbvie | Vraylar | $28 | 1 payment
|
| Novo Nordisk | Wegovy | $16 | 1 payment
|
| GlaxoSmithKline | Shingrix | $15 | 1 payment
|
| ModernaTX | Moderna Covid-19 Vaccine | $14 | 1 payment
|
See all 6 published payments
| Novo Nordisk | Meals · 2024-09-09 | Wegovy | $16 |
| Amgen | Meals · 2024-05-09 | Otezla | $15 |
| Abbvie | Meals · 2024-05-02 | Vraylar | $28 |
| ModernaTX | Meals · 2024-04-22 | Moderna Covid-19 Vaccine | $14 |
| GlaxoSmithKline | Meals · 2024-04-16 | Shingrix | $15 |
| Amgen | Meals · 2024-03-12 | Otezla | $20 |
See earlier years (2023, 2022)
2023: $158
| GlaxoSmithKline | Shingrix | $79 | 5 payments
|
| Amgen | Otezla | $44 | 3 payments
|
| AbbVie | Vraylar | $18 | 1 payment
|
| Novo Nordisk | Wegovy | $16 | 1 payment
|
2022: $55
| Bayer HealthCare Pharmaceuticals | Kerendia | $43 | 3 payments
|
| GlaxoSmithKline | Bexsero | $12 | 1 payment
|
Professional record
- NPI
- 1629506522
- Licence
- MO 2020023474
- Trained
- Washington University School of Medicine, 2017 · 9 years ago
- Group
- Physician Groups Lc · Aging Well Health Care, LLC
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 20 Progress Point Pkwy Ste 108, O Fallon, MO, 63368
- NPI first listed
- 2017-05-23
- NPI last updated
- 2022-07-21
- NPI record certified
- 2021-03-31
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr Rm Hc 435, Stanford, CA, 94305
This office lists an electronic records connection.